相关实验视频
Updated: Jul 24, 2025

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
37.7K
动脉样硬化和动脉样硬化在临床实践中的评估:方法和意义
Jeong Bae Park1, Alberto Avolio2
1JB Lab and Clinic and Department of Precision Medicine and Biostatistics, Yonsei University, Wonju College of Medicine, Seoul, Republic of Korea.
Pulse (Basel, Switzerland)
|July 5, 2023
概括
心血管疾病 (CVD) 是一个主要的全球健康问题,特别是老龄化人口. 这项研究解决了评估动脉样硬化和动脉样硬化的临床需求,这是将风险因素与心血管疾病联系起来的关键指标.
科学领域:
- 血管医学 血管医学
- 老年学是指老年学的学科.
- 心脏病学 心脏病学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因,老龄化人口加剧了风险.
- 动脉样硬化 (动脉硬化) 和动脉样硬化对于血管疾病的进展,桥梁风险因素和心血管疾病至关重要.
- 现有的指导方针涉及心血管疾病风险因素,但评估动脉样硬化和动脉样硬化的临床实用性仍在争论中.
研究的目的:
- 研究评估动脉样硬化和动脉样硬化的临床必要性和实际应用.
- 弥合了解这些血管疾病如何将传统风险因素与临床心血管疾病结果联系的差距.
- 为临床实践提供有关对动脉硬度和斑块积累的评估的信息.
主要方法:
- 这项研究的重点是评估动脉样硬化和动脉样硬化诊断方法的临床效用.
- 这项研究可能涉及分析现有数据或进行与血管健康标志物相关的新评估.
- 具体的方法将详细说明如何测量动脉硬和动脉样变化,并与心血管疾病相关联.
主要成果:
- 这项研究旨在提供支持或反驳动脉样硬化和动脉样硬化例行评估的证据.
- 预计结果将澄清这些条件在预测心血管疾病事件中的作用.
- 这些发现可能会突出先进的血管评估的临床价值.
结论:
- 对动脉样硬化和动脉样硬化的临床评估对于全面了解心血管疾病至关重要.
- 将这些评估纳入临床实践可以改善风险分层和患者管理.
- 需要进一步的研究和指导方针的制定,以标准化这些诊断工具的应用.
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Atherosclerosis IV: Nursing Management
23
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
23
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
17
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17
Coronary Artery Disease I: Introduction
25
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25

